Chestnut Hill, MA

Consultant, Charles River Associates

Representing: Industry

Term ends August 2023

Salman Hussain is a life sciences consultant at Charles River Associates (CRA), and a member of the Board of Directors for the National Alopecia Areata Foundation (NAAF). He has more than seven years of experience in healthcare research and has advised leading pharmaceutical and biotechnology companies across many therapeutic areas (with a specific focus in rare disease), both globally and in the United States.

Prior to joining CRA, Hussain conducted research at Massachusetts General Hospital and The Dartmouth Institute for Health Policy & Clinical Practice, specializing in the rare disease alopecia areata universalis and the interface between dermatology and mental health. While working with NAAF on a PCORI-funded project, he developed a patient-centered outcomes research and comparative clinical effectiveness research training program for patients. He was so inspired after this project that he became a PCORI Ambassador and has continued to advise his pharmaceutical clients and academic researchers on how they can meaningfully engage with patients to inform their research.

In addition to his work in alopecia areata, Hussain has advised and conducted substantial research for pharmaceutical companies to better understand the patient experience in many rare diseases, such as Duchene muscular dystrophy, spinal muscular atrophy types 3 and 4, acute lymphoblastic leukemia, maple syrup urine disease, nemaline myopathy, GM3-synthase deficiency, aromatic 1-amino acid decarboxylase deficiency, and acute hepatic porphyria.

Conflicts of Interest

As of March 4, 2020
  • Charles River Associates, Employer
  • National Alopecia Areata Foundation, Personal Association


Person Type
Panel / Committee